Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmquest
mi
from
Greensboro, NC
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Hometown Urgent Care and Research
mi
from
Dayton, OH
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Hometown Urgent Care and Research
mi
from
Dayton, OH
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Neurology Diagnostics, Inc
mi
from
Dayton, OH
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Neurology Diagnostics, Inc
mi
from
Dayton, OH
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Aventiv Research Inc.
mi
from
Dublin, OH
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Aventiv Research Inc.
mi
from
Dublin, OH
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Philadelphia LLC
mi
from
Philadelphia, PA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Philadelphia LLC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research
mi
from
Mount Pleasant, SC
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research
mi
from
Dakota Dunes, SD
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research
mi
from
Dakota Dunes, SD
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Volunteer Research Group
mi
from
Knoxville, TN
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Volunteer Research Group
mi
from
Knoxville, TN
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute, Inc.
mi
from
Nashville, TN
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute, Inc.
mi
from
Nashville, TN
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Nashville Neuroscience Group, PC
mi
from
Nashville, TN
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Nashville Neuroscience Group, PC
mi
from
Nashville, TN
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Tekton Research
mi
from
Austin, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Tekton Research
mi
from
Austin, TX
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
DM Clinical Research
mi
from
Tomball, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
DM Clinical Research
mi
from
Tomball, TX
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Tidewater Integrated Medical Research
mi
from
Virginia Beach, VA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Tidewater Integrated Medical Research
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Investigation Specialists
mi
from
Kenosha, WI
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Investigation Specialists
mi
from
Kenosha, WI
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Coastal Clinical Research Inc
mi
from
Mobile, AL
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consortium, An AMR Company
mi
from
Tempe, AZ
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consortium, An AMR Company
mi
from
Tempe, AZ
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Tucson, AZ
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Synergy San Diego
mi
from
National City, CA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Synergy San Diego
mi
from
National City, CA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
StudyMetrix Research
mi
from
Saint Peters, MO
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
StudyMetrix Research
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research
mi
from
Norfolk, NE
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research
mi
from
Norfolk, NE
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
CNS Research Science, Inc.
mi
from
Jamaica, NY
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
CNS Research Science, Inc.
mi
from
Jamaica, NY
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc
mi
from
Columbus, OH
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Trial in Adult Subjects With Acute Migraines
BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consortium
mi
from
Tempe, AZ
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consortium
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Encino, CA
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research (Savannah Neurology)
mi
from
Savannah, GA
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research (Savannah Neurology)
mi
from
Savannah, GA
Click here to add this to my saved trials